Immuno-oncology

The latest market intelligence, insights and interviews covering the immuno-oncology therapy industry's most pressing challenges, from combinations to checkpoint inhibitors, improving patient response and manufacturing to market access,

 

We collaborate with leading minds to help you on the road to commercialising advanced therapies and bring them to patients...

 

Immuno-oncology
03/02/2017

Precision medicine requires the delivery of individually adapted medical care based on the genetic characteristics of each patient and their tumour...